These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6432702)
21. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin. Knothe H J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585 [TBL] [Abstract][Full Text] [Related]
22. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ]. Kosakai N; Oguri T Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047 [TBL] [Abstract][Full Text] [Related]
23. Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli. Leggett JE; Craig WA Antimicrob Agents Chemother; 1989 Jan; 33(1):35-40. PubMed ID: 2496656 [TBL] [Abstract][Full Text] [Related]
24. Bactericidal activity of amikacin and gentamicin. Shah RM; Heetderks G; Stille W Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182 [TBL] [Abstract][Full Text] [Related]
25. Serum bactericidal activity of cefoperazone and ceftazidime at increasing dosages against Pseudomonas aeruginosa. Van Laethem Y; Lagast H; Husson M; Klastersky J J Antimicrob Chemother; 1983 Nov; 12(5):475-80. PubMed ID: 6423611 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime. Oizumi K; Hayashi I; Aonuma S; Konno K Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170 [TBL] [Abstract][Full Text] [Related]
27. Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin. Standiford HC; Drusano GL; Fitzpatrick B; Tatem B; Schimpff SC Antimicrob Agents Chemother; 1984 Sep; 26(3):339-42. PubMed ID: 6439114 [TBL] [Abstract][Full Text] [Related]
28. UK-18892, a new aminoglycoside: an in vitro study. Wise R; Andrews JM Antimicrob Agents Chemother; 1978 Aug; 14(2):228-33. PubMed ID: 100050 [TBL] [Abstract][Full Text] [Related]
29. [In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study]. Kazmierczak A; Siebor E; Acar JF; Denis F; Drugeon H; Fleurette J; Sirot J; Soussy CJ; Thabaut A Pathol Biol (Paris); 1991 May; 39(5):384-90. PubMed ID: 1909015 [TBL] [Abstract][Full Text] [Related]
30. Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics. Paglia P; Molinari G; Pesce A; Debbia EA Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):639-43. PubMed ID: 2506028 [TBL] [Abstract][Full Text] [Related]
31. Cefoxitin: synergism with aminoglycosides in vitro. Une T; Osada Y; Ogawa H Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664 [TBL] [Abstract][Full Text] [Related]
32. Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients. Jones P; Bodey GP; Rolston K; Fainstein V; Riccardi S Am J Med; 1988 Jul; 85(1A):3-8. PubMed ID: 3400680 [TBL] [Abstract][Full Text] [Related]
33. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. Pechère JC; Marchou B; Michéa-Hamzehpour M; Auckenthaler R J Antimicrob Chemother; 1986 Mar; 17 Suppl A():11-8. PubMed ID: 3086276 [TBL] [Abstract][Full Text] [Related]
34. Antibiotic combinations against gram-negative bacilli and Staphylococcus aureus in cancer patients: comparative in-vitro and in-vivo activity of cefoperazone and mezlocillin singly or combined together. Standiford HC; Viollier AF; Moody M; Klastersky J; Tatem B; Schimpff SC J Antimicrob Chemother; 1982 Jan; 9 Suppl A():47-9. PubMed ID: 6210682 [No Abstract] [Full Text] [Related]
35. Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae. Moody JA; Fasching CE; Peterson LR; Gerding DN Diagn Microbiol Infect Dis; 1987 Jan; 6(1):59-67. PubMed ID: 3100127 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological evaluation of amikacin in neonates. Howard JB; McCracken GH Antimicrob Agents Chemother; 1975 Jul; 8(1):86-90. PubMed ID: 1164009 [TBL] [Abstract][Full Text] [Related]
37. In vitro antibiotic activity of 11 beta-lactam antibiotics in a cancer center. Landoy Z; Roisilin C; Surgalla MJ; Botzer R; Fitzpatrick JE; Blumenson LE J Surg Oncol; 1985 Sep; 30(1):23-5. PubMed ID: 3935872 [TBL] [Abstract][Full Text] [Related]
38. Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics. Finland M; Garner C; Wilcox C; Sabath LD J Infect Dis; 1976 Nov; 134 SUPPL():S297-307. PubMed ID: 825588 [TBL] [Abstract][Full Text] [Related]
39. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)]. Schassan HH Infection; 1976; 4(2):35-41. PubMed ID: 789246 [TBL] [Abstract][Full Text] [Related]
40. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]